A common variant in the ACE gene is associated with peripheral neuropathy in women with type 2 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 20, Issue 5, 2006, Pages 317-321

  Stephens, Jeffrey W ^a,b   Dhamrait, Sukhbir S ^a   Acharya, Jayshree ^a   Humphries, Steve E ^a   Hurel, Steven J ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

ACE; Diabetes; Female; Gene variant; Neuropathy

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEX DIFFERENCE; STANDARDIZATION;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; SEX FACTORS;

EID: 33747891862     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.07.010     Document Type: Article

References (29)

1. Ahmad J., Siddiqui M.A., and Ahmad H. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. Diabetes Care 20 (1997) 1576-1581
2. Alhenc-Gelas F., Richard J., Courbon D., Warnet J.M., and Corvol P. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: Relationship to environmental and hormonal parameters. Journal of Laboratory and Clinical Medicine 117 (1991) 33-39
3. American Diabetes Association & American Association of Neurology. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes Care 11 (1998) 592-597
4. Araz M., Aynacioglu S., Aktaran S., Alasehirli B., and Okan V. Association between polymorphism of the angiotensin I converting enzyme gene and hypertension in Turkish type II diabetic patients. Acta Medica (Hradec Kralove) 44 (2001) 29-32
5. Araz M., Yilmaz N., Gungor K., Okan V., Kepekci Y., and Sukru Aynacioglu A. Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients. Diabetes Research and Clinical Practice 54 (2001) 95-104
6. Baghai T.C., Schule C., Zill P., Deiml T., Eser D., Zwanger P., Ella R., Rupprecht R., and Bondy B. The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, nut not in men. Neuroscience Letter 363 (2004) 38-42
7. Bedlack R.S., Edelman D., Gibbs III J.W., Kelling D., Strittmatter W., Saunders A.M., and Morgenlander J. APOE genotype is a risk factor for neuropathy severity in diabetic patients. Neurology 60 (2003) 1022-1024
8. Boulton A.J. Lowering the risk of neuropathy, foot ulcers and amputations. Diabetic Medicine 15 Suppl. 4 (1998) S57-S59
9. Boulton A.J., Gries F.A., and Jervall J.A. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Medicine 15 (1998) 508-514
10. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., Riegger G.A., and Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92 (1995) 1387-1388
11. Day I.N., and Humphries S.E. Electrophoresis for genotyping: Microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Analytical Biochemistry 222 (1994) 389-395
12. Feldman E.L. Oxidative stress and diabetic neuropathy: A new understanding of an old problem. Journal of Clinical Investigation 111 (2003) 431-433
13. Freitas-Silva M., Pereira D., Coelho C., Bicho M., Lopes C., and Medeiros R. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genetics and Cytogenetics 155 (2004) 42-46
14. Gallagher P.E., Li P., Lenhart J.R., Chappell M.C., and Brosnihan K.B. Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33 (1999) 323-328
15. Hadjadj S., Gallois Y., Alhenc-Gelas F., Chatellier G., Marre M., Genes N., Lievre M., Mann J., Menard J., and Vasmant D. Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients. Diabetic Medicine 20 (2003) 677-682
16. Lee Y.J., and Tsai J.C. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 50 (2001) 1346-1350
17. Malik R.A. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?. Annals of Medicine 32 (2000) 1-5
18. Malik R.A., Williamson S., Abbott C., Carrington A.L., Iqbal J., Schady W., and Boulton A.J. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised double-blind controlled trial. Lancet 352 (1998) 1978-1981
19. Maschio G., Alberti D., Janin G., Locatelli F., Mann J.F., Motolese M., Ponticelli C., Ritz E., and Zucchelli P. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. New England Journal of Medicine 334 (1996) 939-945
20. O'Dell S.D., Humphries S.E., and Day I.N. Rapid methods for population-scale analysis for gene polymorphisms: The ACE gene as an example. British Heart Journal 73 (1995) 368-371
21. Parving H.H., Larsen M., Hommel E., and Lund-Andersen H. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 32 (1989) 440-444
22. Phillips M.I., and Kagiyama S. Angiotensin II as a pro-inflammatory mediator. Current Opinion in Investigational Drugs 3 (2002) 569-577
23. Proudler A.J., Ahmed A.I., Crook D., Fogelman I., Rymer J.M., and Stevenson J.C. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 346 (1995) 89-90
24. Sanada M., Higashi Y., Nakagawa K., Sasaki S., Kodama I., Tsuda M., Nagai N., and Ohama K. Relationship between the angiotensin-converting enzyme genotype and the forearm vasodilator response to estrogen replacement therapy in postmenopausal women. Journal of the American College of Cardiology 37 (2001) 1529-1535
25. Seshiah P.N., Weber D.S., Rocic P., Valppu L., Taniyama Y., and Griendling K.K. Angiotensin II stimulation of NAD(P)H oxidase activity: Upstream mediators. Circulation Research 91 (2002) 406-413
26. T.D.C.a.C.T.R. Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329 (1993) 977-986
27. Thomas P.K. Diabetic peripheral neuropathies: Their cost to patient and society and the value of knowledge of risk factors for development of interventions. European Neurology 41 Suppl. 1 (1999) 35-43
28. Yorek M.A. The role of oxidative stress in diabetic vascular and neural disease. Free Radical Research 37 (2003) 471-480
29. Yudkin J.S., Andres C., Mohamed-Ali V., Gould M., Panahloo A., Haines A.P., Humphries S., and Talmud P. The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as candidate genes for microalbuminuria. A study in nondiabetic and non-insulin-dependent diabetic subjects. Arteriosclerosis, Thrombosis, and Vascular Biology 17 (1997) 2188-2191